ArticleActa informatica medica : AIM : journal of the Society for Medical Informatics of Bosnia & Herzegovina : casopis Drustva za medicinsku informatiku BiH2024
Assessing the Efficacy of Extended Postoperative Enoxaparin as Thromboprophylaxis for Patients Undergoing Laparoscopic Sleeve Gastrectomy: a Prospective Analysis.
Article in Acta informatica medica : AIM : journal of the Society for Medical Informatics of Bosnia & Herzegovina : casopis Drustva za medicinsku informatiku BiH, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Venous thromboembolism (VTE), encompassing deep venous thrombosis (DVT) and pulmonary embolism (PE), presents significant morbidity and mortality risks post-bariatric surgery. Despite the recognized need for thromboprophylaxis, optimal strategies, particularly regarding the duration and dosing of chemoprophylaxis, remain under debate. Objective: This study evaluates the efficacy of standard versus extended chemoprophylaxis with enoxaparin in preventing VTE following laparoscopic sleeve gastrectomy (LSG) at King Abdullah University Hospital in Irbid, Jordan. Methods: A prospective cohort study included patients undergoing LSG from January to July 2023. Excluding high-risk individuals based on specific criteria, participants were randomized into two groups: standard prophylaxis (Group A) and extended prophylaxis with enoxaparin for 14 days post-discharge (Group B). Both groups were assessed preoperatively and followed up to one month postoperatively for signs of DVT via venous Doppler ultrasound and for any complications related to enoxaparin use. Results: Of the 116 patients studied, no DVT incidents were reported across both groups. Preoperative and postoperative assessments showed significant weight loss, with no complications associated with enoxaparin. Statistical analysis indicated no significant difference in DVT prevention between groups. The study's findings align with existing literature, underscoring the safety of enoxaparin but questioning its impact on DVT incidence post-LSG. Conclusion: The study concludes that extended chemoprophylaxis with enoxaparin post-LSG is safe, with no reported adverse effects. However, its efficacy in significantly reducing postoperative DVT incidence remains uncertain. These outcomes suggest the need for further research with larger sample sizes to optimize thromboprophylaxis strategies, considering patient-specific factors and potential risks.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.